Filing Details
- Accession Number:
- 0001214659-22-003919
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-14 16:37:16
- Reporting Period:
- 2022-03-08
- Accepted Time:
- 2022-03-14 16:37:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293310 | Humanigen Inc | HGEN | Pharmaceutical Preparations (2834) | 770557236 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1857963 | Adrian Kilcoyne | C/O Humanigen, Inc. 830 Morris Turnpike, 4Th Floor Short Hills NJ 07078 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-08 | 7,000 | $2.53 | 7,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-03-09 | 5,000 | $2.78 | 12,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.52 to $2.53, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.75 to $2.80, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
